San Francisco, California, October 17, 2018: TMR Research sheds light on the various market dynamics present in the global metagenomics market. The research report titled, “Metagenomics Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 – 2028”, presents a fair case of the market. Analysts have used primary and secondary research methodologies to offer the readers a thorough insight on the trajectory of the global market for metgenomics.
Metagenomics refers to usage of bioinformatics and sequencing technologies to understand the functioning of the microbial community, interaction and interplay of given microbes within a community. Today, the metagenomic technologies have allowed scientists and researchers to have a better grasp of the microbial ecology and the importance of microbes in geochemical cycles. The demand for this technology is expected to spike in the coming years as chronic diseases continue to be on the rise.
Get Sample Copy of this Report @
The report predicts that the global metagenomic market will be driven by the consumable segment in the coming years. The growing demand for consumables for pre-sequencing is expected to spur market growth in the near future.
Regionally-speaking, Asia Pacific and North America are expected to make their mark on the global metagenomics market. North America’s dominance will be attributable to the strong presence of biotechnology companies in the region. Investments in research and development to widen the scope of application of metagenomics by these companies is expected to bode well for North America metagenomics market. On the other hand, Asia Pacific is expected to show a remarkable growth rate as India and China are trying to build a supportive infrastructure for growth of bioinformatics.
Read Comprehensive Overview of Report @
Some of the key players operating in the global metagenomics market are Danaher Corporation, ELITechGroup, Qiagen, TAKARA BIO INC., Thermo Fisher Scientific, Promega Corporation, and Novogene Corporation.